1
|
Zimmermann JA, Storp JJ, Dicke C, Leclaire MD, Eter N. [Frequency and distribution of the active agent of intravitreal injections in German centers 2015-2021-An oregis study]. DIE OPHTHALMOLOGIE 2024; 121:196-206. [PMID: 38315190 DOI: 10.1007/s00347-024-01986-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/18/2023] [Revised: 11/09/2023] [Accepted: 01/04/2024] [Indexed: 02/07/2024]
Abstract
INTRODUCTION Digitalization in medicine, especially the electronic documentation of patient data, is revolutionizing healthcare systems worldwide. The evaluation of real-world data collected under everyday conditions presents opportunities but also challenges. Electronic medical registries provide a means to compile extensive patient data for scientific inquiries. Oregis is the first nationwide digital registry for health services research established by the German Ophthalmological Society (DOG). Intravitreal operative medicinal injections (IVOM) are among the most frequently performed procedures in ophthalmology. Data on injection numbers and injection frequencies with anti-vascular endothelial growth factor (VEGF) are already available from other countries, whereas data at a national level are not yet available in Germany due to the lack of a nationwide register. It is known that the treatment success of anti-VEGF IVOMs depends largely on the adherence to treatment and thus on the number of injections. There are also differences in cost. In the context of this study, real-world data on the frequency and distribution of intravitreal injections in German centers from 2015 to 2021 were compiled for the first time since the introduction of oregis. The aim of this study is to collect data on the use of anti-VEGF IVOMs in Germany from oregis for the first time and to show the development of injection numbers and anti-VEGF drugs used. At the same time, the possibilities of data retrieval from oregis are demonstrated using a concrete example from daily ophthalmological practice. MATERIAL AND METHODS An automated query of records was performed for all patients who received IVOM at oregis-affiliated healthcare facilities between 2015 and 2021. The number of treated patients and the use of anti-VEGF medications, including aflibercept, bevacizumab, brolucizumab, and ranibizumab, were determined. The data were collected in a pseudonymized and anonymized manner. RESULTS At the time of data collection, 9 German ophthalmological healthcare facilities were affiliated with oregis. In total, 309,152 patients were registered during the observation period, with 8474 receiving IVOMs. Over the observation period, the number of participating centers, patients, and intravitreal injections increased. The proportional share of anti-VEGF agents among the total number of injections varied during the observation period. DISCUSSION Real-world data captured in oregis offer significant potential for enhancing healthcare provision. Oregis enables the depiction of ophthalmological care conditions in Germany and contributes to research and quality assurance. The ability to query the presented data exemplifies the multitude of inquiries through which oregis can contribute to the representation of ophthalmological care in Germany.
Collapse
Affiliation(s)
| | - Jens Julian Storp
- Klinik für Augenheilkunde, Universitätsklinikum Münster, Domagkstr. 15, 48149, Münster, Deutschland
| | - Christopher Dicke
- oregis, Projektmanagement, Deutsche Ophthalmologische Gesellschaft, München, Deutschland
| | - Martin Dominik Leclaire
- Klinik für Augenheilkunde, Universitätsklinikum Münster, Domagkstr. 15, 48149, Münster, Deutschland
| | - Nicole Eter
- Klinik für Augenheilkunde, Universitätsklinikum Münster, Domagkstr. 15, 48149, Münster, Deutschland
| |
Collapse
|
2
|
Spital G, Faatz H. Diabetic Retinopathy - a Common Disease. Klin Monbl Augenheilkd 2023; 240:1060-1070. [PMID: 37666252 DOI: 10.1055/a-2108-6758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/06/2023]
Abstract
Diabetic retinopathy (DR) is one of the most common complications of diabetes mellitus and one of the leading causes of visual impairment in working age individuals in the western world. The treatment of DR depends on its severity, so it is of great importance to detect patients as early as possible, in order to initiate early treatment and preserve vision. Despite currently insufficient screening participation, patients with diabetes already visit ophthalmological practices and clinics above average. Their medical care, including DR diagnostics and treatment has been making up an increasing proportion of ophthalmic activity for years. Since the prevalence of diabetes is increasing dramatically worldwide and a further increase is also predicted for Germany, the challenge for ophthalmologists is likely to grow considerably. As the same time, the diagnostic possibilities for differentiating DR and the therapeutic measures, especially with IVOM therapy, are becoming more and more complex, which increases the time burden in everyday clinical practice. The hope to avoid healthcare deficits and to further improve screening rates and visual acuity prognosis in patients with DR is based, among other things, on camera-assisted screening supported by artificial intelligence. Better diabetes management to reduce the prevalence of DR, as well as longer-acting drugs to treat DR, could also improve the care and help reduce the burden on ophthalmology practices.
Collapse
Affiliation(s)
- Georg Spital
- Augenzentrum am St. Franziskus-Hospital, Münster, Deutschland
| | - Henrik Faatz
- Augenzentrum am St. Franziskus-Hospital, Münster, Deutschland
- Achim-Wessing-Institut für Ophthalmologische Bildgebung, Universität Essen, Deutschland
| |
Collapse
|
3
|
Siegel H, Böhringer D, Wacker K, Josef Lopez Niedenhoff P, Mittelviefhaus H, Reinhard T. Duration of Consultations in an Outpatient Ophthalmology Unit. DEUTSCHES ARZTEBLATT INTERNATIONAL 2023; 120:481-182. [PMID: 37661318 PMCID: PMC10487673 DOI: 10.3238/arztebl.m2023.0037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/22/2022] [Revised: 10/22/2022] [Accepted: 02/06/2023] [Indexed: 09/05/2023]
Affiliation(s)
- Helena Siegel
- Eye Center, Medical Center—University of Freiburg Faculty of Medicine of the University of Freiburg, Freiburg, Germany
| | - Daniel Böhringer
- Eye Center, Medical Center—University of Freiburg Faculty of Medicine of the University of Freiburg, Freiburg, Germany
| | - Katrin Wacker
- Eye Center, Medical Center—University of Freiburg Faculty of Medicine of the University of Freiburg, Freiburg, Germany
| | - Peter Josef Lopez Niedenhoff
- Eye Center, Medical Center—University of Freiburg Faculty of Medicine of the University of Freiburg, Freiburg, Germany
| | - Hans Mittelviefhaus
- Eye Center, Medical Center—University of Freiburg Faculty of Medicine of the University of Freiburg, Freiburg, Germany
| | - Thomas Reinhard
- Eye Center, Medical Center—University of Freiburg Faculty of Medicine of the University of Freiburg, Freiburg, Germany
| |
Collapse
|
4
|
Hartmann A, Bertram B, Siebelmann S, Böhm M, Faber H, Zhour A, Schuster AK. [Career prospects for ophthalmologists under 49 years old : A survey in Germany from 2022]. DIE OPHTHALMOLOGIE 2023; 120:726-733. [PMID: 36729123 DOI: 10.1007/s00347-022-01806-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/07/2022] [Revised: 12/22/2022] [Accepted: 12/28/2022] [Indexed: 02/03/2023]
Abstract
OBJECTIVE The need for care in ophthalmology is constantly increasing due to demographic changes. The study analyzed the current professional situation and future prospects of ophthalmologists under 49 years old. METHODS The survey of members of the German Association of Ophthalmologists (Berufsverband der Augenärzte Deutschlands) and the German Ophthalmologic Society (Deutsche Ophthalmologische Gesellschaft) was conducted in 2022. All members under the age of 49 years received an online questionnaire on the current professional situation as well as future perspectives (desired working hours, form of organization). The results of the survey were additionally compared with the 2016 survey of the German Association of Ophthalmologists. A similar questionnaire was used at that time. RESULTS A total of 1014 people participated in the survey (62.7% women, mean age 39.3 ± 8 years, 75.6% specialists). The response rate to the survey was 25%. Specialist practice from 0 to 5 years showed a higher number of employed ophthalmologists (21% self-employed vs. 32% employed); over time the number of self-employed ophthalmologists increased (6-10 years: 40%, > 10 years: 59.3%). Overall, 46% of women were employed in a practice compared with 33% of men. Of the self-employed specialists, 95.9% said they planned to work in the same type of employment in 10 years as currently. Regarding ophthalmologists' career future, the other employment types showed a desire to move to independent practice. Compared to the 2016 survey, gender differences related to the current type of employment were evident. The number of self-employed women decreased from 43% to 26% and self-employed men decreased from 63% to 39%. The number of ophthalmologists in ambulatory healthcare centers was doubled compared to 2016. Ophthalmologists reported similar future perspectives at both survey times. CONCLUSION The results of the survey of ophthalmologists under 49 years in Germany showed similar perceptions as in 2016. It became clear that the desire to be self-employed in 10 years is very high; however, ophthalmologists expected large practices or medical care centers to prevail in the market. The number of self-employed doctors is decreasing and the desire for self-employment is difficult to realize.
Collapse
Affiliation(s)
- A Hartmann
- Augenklinik und Poliklinik, Fachbereich Ophthalmologie, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland.
| | - B Bertram
- Augenarztpraxis Prof. Bertram & Dr. Helg, Löhergraben 30, 52064, Aachen, Deutschland
| | - S Siebelmann
- Augenärzte Solingen, Zentrum für Augenheilkunde, Uniklinik Köln, Köln, Deutschland
- Bergisches Kompetenzzentrum für Gesundheitsökonomik und Versorgungsforschung, Bergische Universität Wuppertal, Wuppertal, Deutschland
| | - M Böhm
- Augenklinik, Universitätsklinikum Frankfurt, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Deutschland
| | - H Faber
- Departement für Augenheilkunde, Universitätsklinikum Tübingen, Tübingen, Deutschland
- Moorfields Eye Hospital NHS Foundation Trust, London, Großbritannien
| | - A Zhour
- Berufsverband der Augenärzte Deutschlands e. V., Düsseldorf, Deutschland
| | - A K Schuster
- Augenklinik und Poliklinik, Fachbereich Ophthalmologie, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland
| |
Collapse
|
5
|
Storp JJ, Dicke C, Böhringer D, Schargus M, Eter N. [oregis-The German ophthalmological registry]. DIE OPHTHALMOLOGIE 2023; 120:717-725. [PMID: 36635592 DOI: 10.1007/s00347-022-01804-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/19/2022] [Revised: 11/30/2022] [Accepted: 12/21/2022] [Indexed: 01/13/2023]
Abstract
BACKGROUND Medical registries have shown their potential for medical research in different areas of healthcare in the past. The United States of America uses the well-known national ophthalmology registry Intelligent Research in Sight (IRIS®), on the basis of which insights into the ophthalmological care situation in the USA can be gained. Comparable projects do not currently exist in Germany. The oregis is the first disease-independent registry to collect comprehensive data in the field of ophthalmology in Germany for the purpose of healthcare research. METHODS The oregis collects anonymized clinical patient information from all subfields of ophthalmology and makes it available for research purposes. Participating centers read their data into the registry free of charge and preferably in an automated fashion. Currently, the oregis parameter list contains about 600 parameters, of which about 100 are used in the current pilot phase. RESULTS Since its initiation, the German ophthalmological registry oregis has compiled data on more than 1.75 million physician visits for more than 400,000 patients from German ophthalmologic centers. As of late 2022, more than 2.8 million visual acuity measurements and an equal number of intraocular pressure measurements have been recorded. DISCUSSION The aim of the oregis project is to establish a nationwide ophthalmology databank that forms the basis for a learning healthcare system in the field of ophthalmology. With the help of continuous updating, oregis can also illustrate short-term innovations in ophthalmological care.
Collapse
Affiliation(s)
- Jens Julian Storp
- Klinik für Augenheilkunde, Universitätsklinikum Münster, Domagkstr. 15, 48149, Münster, Deutschland.
| | - Christopher Dicke
- oregis, Projektmanagement, Deutsche Ophthalmologische Gesellschaft, München, Deutschland
| | - Daniel Böhringer
- Klinik für Augenheilkunde, Universitätsklinikum Freiburg, Freiburg, Deutschland
| | - Marc Schargus
- Klinik für Augenheilkunde, Asklepios Klinik Nord-Heidberg, Hamburg, Deutschland
- Klinik für Augenheilkunde, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland
| | - Nicole Eter
- Klinik für Augenheilkunde, Universitätsklinikum Münster, Domagkstr. 15, 48149, Münster, Deutschland
| |
Collapse
|
6
|
Held LA, Wewetzer L, Steinhäuser J. Determinants of the implementation of an artificial intelligence-supported device for the screening of diabetic retinopathy in primary care - a qualitative study. Health Informatics J 2022; 28:14604582221112816. [PMID: 35921547 DOI: 10.1177/14604582221112816] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Diabetic retinopathy is a microvascular complication of diabetes mellitus that is usually asymptomatic in the early stages. Therefore, its timely detection and treatment are essential. First pilot projects exist to establish a smartphone-based and AI-supported screening of DR in primary care. This study explored health professionals' perceptions of potential barriers and enablers of using a screening such as this in primary care to understand the mechanisms that could influence implementation into routine clinical practice. Semi-structured telephone interviews were conducted and analysed with the help of qualitative analysis of Mayring. The following main influencing factors to implementation have been identified: personal attitude, organisation, time, financial factors, education, support, technical requirement, influence on profession and patient welfare. Most determinants could be relocated in the behaviour change wheel, a validated implementation model. Further research on the patients' perspective and a ranking of the determinants found is needed.
Collapse
Affiliation(s)
- Linda A Held
- Institute of Family Medicine, 54360University Medical Center Schleswig-Holstein, Campus Lübeck, Germany
| | - Larisa Wewetzer
- Institute of Family Medicine, 54360University Medical Center Schleswig-Holstein, Campus Lübeck, Germany
| | - Jost Steinhäuser
- Institute of Family Medicine, 54360University Medical Center Schleswig-Holstein, Campus Lübeck, Germany
| |
Collapse
|
7
|
Impact of the COVID-19 pandemic's first wave on the care and treatment situation of intravitreal injections in a German metropolitan region. Graefes Arch Clin Exp Ophthalmol 2022; 260:1877-1886. [PMID: 35006330 PMCID: PMC8743739 DOI: 10.1007/s00417-021-05521-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2021] [Revised: 12/06/2021] [Accepted: 12/10/2021] [Indexed: 12/13/2022] Open
Abstract
Purpose This study aims to evaluate the impact of the first coronavirus 2019 (COVID-19) wave in 2020 on patients scheduled for intravitreal injections (IVI) in a German metropolitan region. Methods We performed a multicentre prospective survey and retrospective analysis of the records of patients treated with intravitreal injections during the 20-week period from March to July 2020 in all four hospital eye departments in the city of Hamburg using a questionnaire (on treatment adherence, SarsCoV2-related personal, familial and social data) and treatment data. Results A total of 1038 patients (2472 IVI, 1231 eyes) and 818 questionnaires were evaluated. Longer duration of therapy, lower visual acuity (VA) of the treated and higher VA of the fellow untreated eye was were associated with a higher probability of visit cancellation. Every additional year of life posed a 2.6% lower risk of noncompliance. A COVID-19 infection in the family environment displayed a 5.5-fold chance of visit cancellation. Patients treated for neovascular age-related macular degeneration (nAMD) had a 36% reduced risk of visit cancellation compared to patients with diabetic macular oedema (DME). Conclusion A long preceding treatment period, low VA of the treated eye, high VA of the untreated eye, COVID-19 in the family and DME were identified as risk factors for IVI visit cancellations during the COVID-19 pandemic. Compliance to treatment might be improved in the future by taking these risk factors into account when scheduling patients for IVI during the exceptional circumstances of a pandemic. Supplementary Information The online version contains supplementary material available at 10.1007/s00417-021-05521-5.
Collapse
|
8
|
Wintergerst MWM, Bejan V, Hartmann V, Schnorrenberg M, Bleckwenn M, Weckbecker K, Finger RP. Telemedical Diabetic Retinopathy Screening in a Primary Care Setting: Quality of Retinal Photographs and Accuracy of Automated Image Analysis. Ophthalmic Epidemiol 2021; 29:286-295. [PMID: 34151725 DOI: 10.1080/09286586.2021.1939886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Background: Screening for diabetic eye disease (DED) and general diabetes care is often separate, which leads to delays and low adherence to DED screening recommendations. Thus, we assessed the feasibility, achieved image quality, and possible barriers of telemedical DED screening in a point-of-care general practice setting and the accuracy of an automated algorithm for detection of DED.Methods: Patients with diabetes were recruited at general practices. Retinal images were acquired using a non-mydriatic camera (CenterVue, Italy) by medical assistants. Images were quality assessed and double graded by two graders. All images were also graded automatically using a commercially available artificial intelligence (AI) algorithm (EyeArt version 2.1.0, Eyenuk Inc.).Results: A total of 75 patients (147 eyes; mean age 69 years, 96% type 2 diabetes) were included. Most of the patients (51; 68%) preferred DED screening at the general practice, but only twenty-four (32%) were willing to pay for this service. Images of 63 patients (84%) were determined to be evaluable, and DED was diagnosed in 6 patients (8.0%). The algorithm's positive/negative predictive values (95% confidence interval) were 0.80 (0.28-0.99)/1.00 (0.92-1.00) and 0.75 (0.19-0.99)/0.98 (0.88-1.00) for detection of any DED and referral-warranted DED, respectively.Overall, the number of referrals was 18 (24%) for manual telemedical assessment and 31 (41%) for the artificial intelligence (AI) algorithm, resulting in a relative increase of referrals by 72% when using AI.Conclusions: Our study shows that achieved overall image quality in a telemedical GP-based DED screening was sufficient and that it would be accepted by medical assistants and patients in most cases. However, good image quality and integration into existing workflow remain challenging. Based on these findings, a larger-scale implementation study is warranted.
Collapse
Affiliation(s)
| | - Veronica Bejan
- Department of Ophthalmology, University Hospital Bonn, Bonn, Germany
| | - Vera Hartmann
- Department of Ophthalmology, University Hospital Bonn, Bonn, Germany
| | - Marina Schnorrenberg
- Institute of General Practice and Interprofessional Care, Faculty of Health/Department of Medicine, University Witten/Herdecke, Witten, Germany
| | - Markus Bleckwenn
- Department of General Practice, Medical Faculty, University of Leipzig, Leipzig, Germany
| | - Klaus Weckbecker
- Institute of General Practice and Interprofessional Care, Faculty of Health/Department of Medicine, University Witten/Herdecke, Witten, Germany
| | - Robert P Finger
- Department of Ophthalmology, University Hospital Bonn, Bonn, Germany
| |
Collapse
|
9
|
Frech S, Guthoff RF, Gamael A, Helbig C, Diener A, Ritzke M, Wollny A, Altiner A. Patterns and Facilitators for the Promotion of Glaucoma Medication Adherence-A Qualitative Study. Healthcare (Basel) 2021; 9:healthcare9040426. [PMID: 33916976 PMCID: PMC8067555 DOI: 10.3390/healthcare9040426] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2021] [Revised: 03/25/2021] [Accepted: 03/29/2021] [Indexed: 11/16/2022] Open
Abstract
Primary open-angle glaucoma (POAG) is a chronic optic neuropathy causing irreversible nerve fiber damage. Initially asymptomatic, it progresses slowly without any notable sign of vision loss, thus early detection and treatment is essential. The standard treatment being non-invasive topical administration of eye drops harbors the problem of patients not being adherent. This study aimed to explore the experiences and thoughts of glaucoma patients about their medication management to improve our knowledge on how adherence works for the individual patient. Narrative interviews were conducted with 21 glaucoma patients. Data were analyzed using inductive content analysis and the documentary method. Different patterns of adherence were identified which depended on personal biographies, living conditions, or the patient's knowledge about the disease. Interpreting eye drop medication as a ritual, a task, or routine was helpful for some patients, whereas other patients, who were aware of the consequences of not taking the drops, were motivated by intrinsic or extrinsic factors. The patterns identified here represent strategies for managing and adhering to daily glaucoma medication at an individual level. Linking daily drop application or medication intake to these patterns may help to promote correct medication management of patients with chronic diseases who lack a regular medication regimen.
Collapse
Affiliation(s)
- Stefanie Frech
- Department of Ophthalmology, Rostock University Medical Center, Doberaner Str. 140, 18057 Rostock, Germany;
- Correspondence:
| | - Rudolf F. Guthoff
- Department of Ophthalmology, Rostock University Medical Center, Doberaner Str. 140, 18057 Rostock, Germany;
| | - Amin Gamael
- Ophthalmic Care Unit, Rostock University Medical Center, Doberaner Str. 142, 18057 Rostock, Germany;
| | - Christian Helbig
- Institute of General Practice, Rostock University Medical Center, Doberaner Str. 142, 18057 Rostock, Germany; (C.H.); (A.D.); (M.R.); (A.W.); (A.A.)
| | - Annette Diener
- Institute of General Practice, Rostock University Medical Center, Doberaner Str. 142, 18057 Rostock, Germany; (C.H.); (A.D.); (M.R.); (A.W.); (A.A.)
| | - Manuela Ritzke
- Institute of General Practice, Rostock University Medical Center, Doberaner Str. 142, 18057 Rostock, Germany; (C.H.); (A.D.); (M.R.); (A.W.); (A.A.)
| | - Anja Wollny
- Institute of General Practice, Rostock University Medical Center, Doberaner Str. 142, 18057 Rostock, Germany; (C.H.); (A.D.); (M.R.); (A.W.); (A.A.)
| | - Attila Altiner
- Institute of General Practice, Rostock University Medical Center, Doberaner Str. 142, 18057 Rostock, Germany; (C.H.); (A.D.); (M.R.); (A.W.); (A.A.)
| |
Collapse
|
10
|
Abstract
BACKGROUND The main goals of glaucoma treatment are to preserve the visual function and maintain as high a quality of life as possible at a cost acceptable to society. Therefore, it is crucial to carefully observe each individual patient in order to determine an individual and personalized treatment approach. MATERIAL AND METHODS This article summarizes the advantages and disadvantages of medicinal glaucoma treatment as well as traditional methods of glaucoma surgery, based on the current state of knowledge. The article explains the various mechanisms of action of new minimally invasive procedures, introduces the methods mostly commonly used in Germany and gives recommendations for preoperative care and postoperative follow-up. RESULTS/CONCLUSION In addition to the plethora of medicinal glaucoma treatments and classical surgical procedures, new minimally invasive treatment alternatives have become available in the past few years. The latter are an option for an earlier surgical intervention, especially in naïve or previously treated patients who appear to be unsuitable for medicinal treatment.
Collapse
Affiliation(s)
- Esther M Hoffmann
- Augenklinik und Poliklinik, Universitätsmedizin Mainz, Mainz, Deutschland.
| | - Fritz Hengerer
- Bürgerhospital Frankfurt a. M., Frankfurt a. M., Deutschland
| | - Karsten Klabe
- Breyer - Kaymak - Klabe Augenchirurgie, Düsseldorf, Deutschland
| | - Marc Schargus
- Asklepios Augenklinik Nord-Heidberg Hamburg, Hamburg, Deutschland
- Universitäts-Augenklinik Düsseldorf, Düsseldorf, Deutschland
| | - Hagen Thieme
- Universitätsaugenklinik Magdeburg, Magdeburg, Deutschland
| | | |
Collapse
|
11
|
Stahl A. The Diagnosis and Treatment of Age-Related Macular Degeneration. DEUTSCHES ARZTEBLATT INTERNATIONAL 2020; 117:513-520. [PMID: 33087239 DOI: 10.3238/arztebl.2020.0513] [Citation(s) in RCA: 70] [Impact Index Per Article: 17.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/16/2020] [Revised: 02/16/2020] [Accepted: 06/12/2020] [Indexed: 12/11/2022]
Abstract
BACKGROUND Age-related macular degeneration (AMD) is thought to cause approximately 9% of all cases of blindness worldwide. In Germany, half of all cases of blindness and high-grade visual impairment are due to AMD. In this review, the main risk factors, clinical manifestations, and treatments of this disease are presented. METHODS This review is based on pertinent publications retrieved by a selective search in PubMed for original articles and reviews, as well as on current position statements by the relevant specialty societies. RESULTS AMD is subdivided into early, intermediate, and late stages. The early stage is often asymptomatic; patients in the other two stages often have distorted vision or central visual field defects. The main risk factors are age, genetic predisposition, and nicotine consumption. The number of persons with early AMD in Germany rose from 5.7 million in 2002 to ca. 7 million in 2017. Late AMD is subdivided into the dry late form of the disease, for which there is no treatment at present, and the exudative late form, which can be treated with the intravitreal injection of VEGF inhibitors. CONCLUSION More research is needed on the dry late form of AMD in particular, which is currently untreatable. The treatment of the exudative late form with VEGF inhibitors is labor-intensive and requires a close collaboration of the patient, the ophthalmologist, and the primary care physician.
Collapse
Affiliation(s)
- Andreas Stahl
- Department of Ophthalmology, University Medicine Greifswald
| |
Collapse
|
12
|
Wagner H, Stifter J, Engesser D, Atzrodt L, Betancor PK, Böhringer D, Faessler M, Wuermeling M, Reinhard T. Ophthalmic Care in Nursing Homes for the Blind: A Growing Challenge. Klin Monbl Augenheilkd 2020; 237:1326-1333. [PMID: 32869245 DOI: 10.1055/a-1194-5381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
BACKGROUND The demographic change in Germany will lead to an increase in irreversible age-related eye diseases. This will increase the need for specialised care facilities for visually impaired people. Due to reduced mobility, residents in such facilities often do not receive adequate ophthalmological care. New concepts must therefore be considered for this group of patients. One approach is to set up an ophthalmological examination unit within the facility combined with regular visits by an ophthalmologist. We now present the experience with such a model in a home for the blind. PATIENTS AND METHODS The project was initiated in 2009. Since then there have been visits by medical staff of the Eye Center at Medical Center, University of Freiburg, every two weeks. All patient records (2010 - 2017) were reviewed systematically. The following data were extracted in a structured and anonymous way: Age at first presentation, gender, ophthalmological diagnoses and if a therapy was initiated. This data set was finally analysed descriptively. RESULTS Out of 130 residents aged between 48 and 100 years, half were between 78 and 90 years old. The youngest resident was 48, the oldest 100 years old. The median visual acuity was 0.2. Sixty percent of the residents had at least mild visual impairment according to the WHO (visual acuity < 0.5; category 1 - 6). In one of 6 - 7 residents, visual acuity could not be determined using Snellen charts. The most frequent ophthalmological diagnoses included cataract (44%), age-related macular degeneration (36%) and glaucoma (29%). In 67 residents (52%), the ophthalmological examination lead to treatment, such as application of local therapy or planning an operation. CONCLUSION In every second resident, the ophthalmologist's visit lead to treatment during the observation period. This underlines the difficulty of providing ophthalmological care even in specialised institutions for the blind and visually impaired, which is possibly due to the residents' mobility problems. The concept presented here has established a low-threshold, sustainable and high-quality ophthalmological service on site. These positive experiences indicate that corresponding measures may also be useful for other locations. However, in order to implement such a project on a larger scale, suitable financing and accounting modalities for the construction measures, the nursing staff and the ophthalmological procedure still need to be developed.
Collapse
Affiliation(s)
- Helena Wagner
- Klinik für Augenheilkunde, Universitätsklinikum Freiburg.,Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg
| | - Julia Stifter
- Klinik für Augenheilkunde, Universitätsklinikum Freiburg.,Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg
| | - Diana Engesser
- Klinik für Augenheilkunde, Universitätsklinikum Freiburg.,Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg
| | - Lisa Atzrodt
- Klinik für Augenheilkunde, Universitätsklinikum Freiburg.,Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg
| | - Paola Kammrath Betancor
- Klinik für Augenheilkunde, Universitätsklinikum Freiburg.,Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg
| | - Daniel Böhringer
- Klinik für Augenheilkunde, Universitätsklinikum Freiburg.,Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg
| | | | - Martin Wuermeling
- Augenarztpraxis Titisee-Neustadt, Augennetz Südbaden, Titisee-Neustadt
| | - Thomas Reinhard
- Klinik für Augenheilkunde, Universitätsklinikum Freiburg.,Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg
| |
Collapse
|
13
|
Jacobsen C, Volkmann I, Wedegärtner F, Harris J, Bertram B, Gass P, Bambas B, Framme C. [Experiences of aggression and violence against ophthalmologists]. Ophthalmologe 2020; 117:775-785. [PMID: 32025792 DOI: 10.1007/s00347-020-01039-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND The media have reported an increased willingness of patients and relatives to use violence against medical personnel. So far a few studies have been carried out on this topic and the data situation is correspondingly weak. Ophthalmologists in particular have close contact with patients at the slit lamp and are often alone with patients. METHODS A questionnaire was developed based on the perception of prevalence of aggression scale (POPAS) questionnaire and the survey on aggression and violence among general practitioners. In autumn 2018, all members of the German Ophthalmological Society (DOG) and the Professional Association of Ophthalmologists (BVA) received an invitation by e‑mail to complete the questionnaire online. RESULTS Of the 9411 ophthalmologists contacted a total of 1508 (age 49 ± 12 years) took part in the survey (16%). Of the respondents 806 (53.7%) were female and 1139 (75.5%) participants worked in practices. A total of 1264 (83.3%) ophthalmologists had experienced aggression/violence in their work, 986 (65%) respondents had already experienced verbal assaults without threats, 363 (24.1%) doctors reported experiences with threats of physical violence and 30 (2%) participants had received medical treatment for severe physical violence. Sexual intimidation/harassment was affirmed by 322 (21.4%) of respondents, of whom 243 (75.5%) were female and 533 (47.9%) doctors felt that aggressive/violent behavior had increased in the last 5 years. CONCLUSION The high number of participants indicates the high relevance of the topic. The survey produced astonishing results, which should lead to further discussion and action to improve the safety of employees.
Collapse
Affiliation(s)
- Christina Jacobsen
- Universitätsklinik für Augenheilkunde, Medizinische Hochschule Hannover (MHH), Hannover, Deutschland.
| | - I Volkmann
- Universitätsklinik für Augenheilkunde, Medizinische Hochschule Hannover (MHH), Hannover, Deutschland
| | - F Wedegärtner
- Universitätsklinik für Psychiatrie, Sozialpsychiatrie und Psychotherapie, MHH, Hannover, Deutschland
| | - J Harris
- Berufsverband der Augenärzte Deutschlands e. V., Düsseldorf, Deutschland
| | - B Bertram
- Berufsverband der Augenärzte Deutschlands e. V., Düsseldorf, Deutschland
| | - P Gass
- Deutsche Ophthalmologische Gesellschaft e. V., München, Deutschland
| | - B Bambas
- Berufsverband der Augenärzte Deutschlands e. V., Düsseldorf, Deutschland
| | - C Framme
- Universitätsklinik für Augenheilkunde, Medizinische Hochschule Hannover (MHH), Hannover, Deutschland
| |
Collapse
|